It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?


April 12, 2024

The first drug shown to slow Alzheimer's disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have rejected coverage.

Doctors also expect some patients will hesitate to take Leqembi due to its limited impact and potential side effects. They say it will take years to learn how best to deploy the drug and that work must be done to improve diagnosis.

"This is the start of a very exciting journey," said Dr. Ambar Kulshreshtha, a suburban Atlanta family physician focused on dementia patients.

More than 6 mil...

For access to this article please sign in or subscribe.


Reader Comments(0)


Our Family of Publications Includes:


Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2024